开放期刊系统

冠状动脉易损斑块的评估研究进展

宋 红飞, 杨 华, 熊 攀

摘要

冠状动脉易损斑块是冠心病发生和发展的关键因素之一,近年来该领域的研究不断深入。随着影像学技术的进步、
生物标志物的发现以及相关临床研究的开展,研究者们逐渐揭示了冠状动脉易损斑块的形成机制并不断探索其评估方法。
准确评估易损斑块不仅可以帮助预测冠心病的风险,还能为临床干预提供重要依据。因此,本文通过综述目前冠状动脉易
损斑块评估相关技术的研究进展,期望为冠状动脉易损斑块的评估和风险预测以及冠心病的管理提供新的视角和思路。

关键词

冠状动脉易损斑块;影像学技术;生物标志物;风险预测

全文:

PDF

参考

[1] 王永霞 , 朱斌 . 麝香保心丸联合地尔硫卓治疗老年冠

心病 稳定型心绞痛的临床疗效 [J]. 成都医学院学报 ,2020,15

(3):373-375.

[2] 贾磊 , 高钊 . 冠心病不稳定型心绞痛合并冠脉狭窄患

者 CRP、Angptls2、CTRP1 水平变化及临床意义 [J]. 海南医

学 ,2020,31(8):966-968.

[3]Papaioannou TG, Kalantzis C, Katsanos E, Sanudo D,

Varanasi’s M, Bouzoukis D. Personalized Assessment of the

Coronary Atherosclerotic Arteries by Intravascular Ultrasound

Imaging: Hunting the Vulnerable Plaque. J Pers Med. 2019;9(1).

Published 2019 Jan 24.

[4]Föllmer B, Williams MC, Dey D, et al. Roadmap

on the use of artificial intelligence for imaging of vulnerable

atherosclerotic plaque in coronary arteries. Nat Rev Cardio.

2024;21(1):51-64.

[5]Kay FU, Canan A, Abbara S. Future Directions in

Coronary CT Angiography: CT-Fractional Flow Reserve, Plaque

Vulnerability, and Quantitative Plaque Assessment. Korean Circ J.

2020;50(3):185-202.

[6]Yamazaki T, Nishi T, Saito Y, et al. Discrepancy between

plaque vulnerability and functional severity of angiographically

intermediate coronary artery lesions. Cardiovasc Intern Ther.

2022;37(4):691-698.

[7]Barbieri L, Tumminello G, Fichtner I, et al. PCSK9 and

Coronary Artery Plaque-New Opportunity or Red Herring? Curr

Atheroscler Rep. 2024;26(10):589-602.

[8]Zhang S , Liu Y , Cao Y , et al. Targeting the

Microenvironment of Vulnerable Atherosclerotic Plaques: An

Emerging Diagnosis and Therapy Strategy for Atherosclerosis. Adv

Mater. 2022;34(29):e2110660.

[9]Mintz GS, Bourantas CV, Chamié D. Intravascular

Imaging for Percutaneous Coronary Intervention Guidance and

Optimization: The Evidence for Improved Patient Outcomes. J Soc

Cardiovasc Angiogr Interv. 2022 Nov-Dec;1(6):100413. Published

2022 Nov-Dec.

[10] Sang CJ 3rd, Prejean S, Von Mering G, Ahmed M, Law

MA. Intravascular ultrasound use for stent optimization during

percutaneous coronary intervention in a toddler with post-surgical

stenosis after coronary reimplantation for ALCAPA. J Cardiol

Cases. 2020;22(2):77-80. Published 2020 Aug.

[11] Singh A, Nasir U, Segal J, Waheed TA, Ameen M,

Hafeez H. The utility of ultrasound and computed tomography

in the assessment of carotid artery plaque vulnerability-A mini

review. Front Cardiovasc Med. 9:1023562. Published 2022.

[12] Kim H, Ahn JM, Kang DY, et al. Management of

Coronary Vulnerable Plaque With Medical Therapy or Local

Preventive Percutaneous Coronary Intervention. JACC Asia.

2024;4(6):425-443. Published 2024 Jun.

[13] Kubo T. Optical Coherence Tomography in Vulnerable

Plaque and Acute Coronary Syndrome. Interv Cardiol Clin.

2023;12(2):203-214.

[14] Yuki H, Sugiyama T, Suzuki K, et al. Coronary

Inflammation and Plaque Vulnerability: A Coronary Computed

Tomography and Optical Coherence Tomography Study. Circ

Cardiovasc Imaging. 2023;16(3):e014959.

[15] Milzi A, Landi A, Dettori R, Burgmaier K, Reith S,

Burgmaier M. Multimodal Intravascular Imaging of the Vulnerable

Coronary Plaque. Echocardiography. 2024;41(12):e70035.

[16] Biccirè FG, Varricchione G, Debelak C, et al. [From

regression to stabilization: new insights into the evolution

of coronary atherosclerotic plaque]. G Ital Cardiol (Rome).

2022;23(12):948-957.

[17] Fujimoto D, Usui E, Vergallo R, et al. Relationship

Between Coronary Artery Calcium Score and Vulnerability of

Culprit Plaque Assessed by OCT in Patients With Established

Coronary ArteryDisease.CircCardiovascImaging.2025;18(1)

:e017099.

[18] Henein MY, Vancheri S, Bajraktari G, Vancheri F.

Coronary Atherosclerosis Imaging. Diagnostics (Basel). 2020;10(2).

Published 2020 Jan 24.

[19] Morariu M, Hodas R, Benedek T, et al. Impact of

inflammation-mediated response on pan-coronary plaque

vulnerability, myocardial viability and ventricular remodeling in

the postinfarction period - the VIABILITY study: Protocol for a

non-randomized prospective clinical study.Medicine (Baltimore).

2019;98(17): e15194.

[20] Wang X, Li J, Wang X, Gao J, Jing H, Xing Y. Clinical

Evaluation of High-Resolution MRI Combined With DWI in

Identifying Vulnerable Carotid Plaque. Neurologist. 2023;28(1):5-

10. Published 2023 Jan 1.

[21] Gonçalves I, Singh P, Tengryd C, et al. sTRAIL-R2

(Soluble TNF [Tumor Necrosis Factor]-Related ApoptosisInducing Ligand Receptor 2) a Marker of Plaque Cell Apoptosis

and Cardiovascular Events. Stroke. 2019;50(8):1989-1996.

[22] Tong W, Hui H, Shang W, et al. Highly sensitive

magnetic particle imaging of vulnerable atherosclerotic plaque

with active myeloperoxidase-targeted nanoparticles. Theranostics.

2021;11(2):506-521. Published 2021.

[23] Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva

JC, Abdalla DSP. Prodigiosin Modulates the Immune Response

and Could Promote a Stable Atherosclerotic Lession in C57bl/6

Ldlr-/- Mice. Int J Mol Sci. 2020;21(17). Published 2020

Sep 3.

[24] Zhang L, Lyu Q, Zhou W, et al. High systemic immuneinflammation index is associated with carotid plaque vulnerability:

New findings based on carotid ultrasound imaging in patients with

acute ischemic stroke. Front Neurol. 13:959531. Published 2022.

[25] Jia H, Zhang W, Jia S, et al. Correlation between

triglyceride glucose index and coronary plaque: An observational

study. Medicine (Baltimore). 2024;103(37): e39576.

[26] Kezdoglou NP, Khattab E, Vlahakis N, Pasturages

N, Lambadi Ari V. A new approach of statin therapy in carotid

atherosclerosis: Targeting indices of plaque vulnerability on the top

of lipid-lowering. A narrative review. Cardio Pol. 2022;80(9):880-

890.

[27] Nooti S, Rai V, Radwan MM, et al. Oxidized Lowdensity Lipoproteins and Lipopolysaccharides Augment Carotid

Artery Plaque Vulnerability in Hypercholesterolemic Microswine.

Cardiol Cardiovasc Med. 2023;7(4):273-294. doi:10.26502/

fccm.92920338

[28] Linton MF, Yancey PG, Tao H, Davies SS. HDL

Function and Atherosclerosis: Reactive Dicarbonyls as Promising

Targets of Therapy. Circ Res. 2023;132(11):1521-1545.

doi:10.1161/CIRCRESAHA.123.321563

[29] Papakonstantinou E, Dragoman K, Mitsi’s T, Choruses

GP, Vlachakis D. Milk exosomes and a new way of communication

between mother and child. Embed J. 29. doi:10.14806/

ej.29.0.1050


(6 摘要 Views, 5 PDF Downloads)

Refbacks

  • 当前没有refback。